Background/Objectives: Dietary addition of either conjugated linoleic acid (CLA) or n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFAs) has been shown to alter adiposity and circulating lipids, risk markers of cardiovascular diseases. However, CLA may decrease insulin sensitivity, an effect that may be reversed by n-3 LC-PUFA. Thus, the potential of CLA plus n-3 LC-PUFA to affect insulin secretion and sensitivity in non-diabetic young and old, lean and obese subjects was tested.
Subjects/Methods: CLA (3 g daily) plus n-3 LC-PUFA (3 g daily) or control oil (6 g daily) was given to lean (n = 12; BMI 20-26 kg/m(2)) or obese (n = 10; BMI 29-35 kg/m(2)) young (20-37 years old) or lean (n = 16) or obese (n = 11) older men (50-65 years) for 12 weeks. The study had a double-blind, placebo-controlled randomized crossover design, and primary end points were insulin secretion and sensitivity during a standardized meal test, evaluated by modeling glucose, insulin and C-peptide data.
Results: The combination was well tolerated. There was no significant difference in fasting levels of glucose, insulin or C-peptide after CLA/n-3 LC-PUFA treatment compared with control oil. Neither insulin secretion nor estimated sensitivity was affected by CLA/n-3 LC-PUFA in lean or obese young subjects or in older lean subjects. However, in older obese subjects, estimated insulin sensitivity was reduced with CLA/n-3 LC-PUFA compared with control (P = 0.024).
Conclusions: The results do not support beneficial effects of CLA/n-3 LC-PUFA for beta-cell dysfunction or insulin resistance in humans but suggest that insulin sensitivity in older obese subjects is reduced. European Journal of Clinical Nutrition (2009) 63, 778-786; doi:10.1038/ejcn.2008.45; published online 3 September 2008
- n-3 LC-PUFA
- insulin secretion
- insulin sensitivity
- BETA-CELL FUNCTION
- GLUCOSE-TOLERANCE TEST
- WHITE ADIPOSE-TISSUE
- METABOLIC SYNDROME
- OBESE MEN